No. 20-1480

George P. Naum, III v. United States

Lower Court: Fourth Circuit
Docketed: 2021-04-22
Status: GVR
Type: Paid
Relisted (6) Experienced Counsel
Tags: 21-cfr-1306-04 21-usc-841 controlled-substances criminal-prosecution medical-practice opioid-prescription professional-standards statutory-interpretation united-states-v-moore
Key Terms:
SocialSecurity Privacy
Latest Conference: 2022-06-29 (distributed 6 times)
Question Presented (AI Summary)

Can the elements of 21 U.S.C. §841(a)(1) as defined in United States v. Moore, 423 U.S. 122 (1975) requiring the Government to prove unlawful distribution of a controlled substance 'outside the usual course of professional practice' and 'for other than a legitimate medical purpose' be applied in the disjunctive permitting the Government to prove only that a prescription was prescribed 'outside the usual course of professional practice' or 'outside the bounds of professional practice' solely for violation of a professional standard without regard to the medical legitimacy of the medication?

Question Presented (OCR Extract)

QUESTION PRESENTED FOR REVIEW Justice Potter Steward’s concerns raised at oral argument in United States v. Moore, 423 U.S. 122 (1975) over 40 years ago have become a reality. And is it not true that historically most, if not all of the great breakthroughs and advances in medical science are made by people who did not follow the conventional way of doing things. They followed a new way, their way, and most of the conventional physicians of their day would have disagreed with them because this is not the way it has always been done... it bothers me that this kind of evidence . . . is the basis for criminal liability. This man was a physician, he was not a fraud. : United States v. Moore, 423 U.S. 122 (1975); Oral Argument in United States v. Moore, Oyez, (last visited Jan 27, 2021). : Asa result of what this Court has declared as ambiguous language in 21 U.S.C. §841 and 21 C.F.R. §1306.04, physicians in the United States are being convicted for professional disagreements and violations of the “standard of care” when prescribing opioids. United States v. Moore, 423 U.S. 122, 135; 96 S. Ct. 335, 345 (1975). The Circuits are widely split on their interpretation of 21 U.S.C. §841 and 21 C.F.R. §1306.04 and it is time for this Court to revisit United States v. Moore. George P. Naum III was ‘convicted of violations of 21 U.S.C. §841(a)(1) and 21 U.S.C. §846 for prescribing Suboxone, a drug used to treat opioid use disorder. The central issue at trial was his use of nurses to expand the availability of patient care consistent with SAMHSA regulations. At trial, the trial court held that the elements of 21 U.S.C. §841(a)(1) as applied to a physician can be applied in the disjunctive thereby permitting the Government to procced on. a theory that prescriptions were issued either “beyond the bounds of professional practice” or i “for other than a legitimate medical purpose.” This permitted the Government to prosecute and convict Dr. Naum solely for violating professional standards. Further, the trial court prohibited expert testimony regarding the medical legitimacy of the prescriptions and hospital programs that operated in the same manner as Defendant. The question presented is: Can the elements of 21 U.S.C. §841(a)(1) as defined in United States v. Moore, 423 U.S. 122 (1975) requiring the Government to prove unlawful distribution of a controlled substance “outside the usual course of professional practice” and “for other than a legitimate medical purpose” be applied in the disjunctive permitting the Government to prove only that a prescription was prescribed “outside the usual course of professional practice” or “outside the bounds _ of professional practice” solely for violation of a professional standard without regard to the medical legitimacy of the medication? ii

Docket Entries

2022-08-01
JUDGMENT ISSUED
2022-06-30
Petition GRANTED. Judgment VACATED and case REMANDED for further consideration in light of <i>Xiulu Ruan</i> v. <i>United States</i>, 597 U. S. ___ (2022).
2022-06-29
DISTRIBUTED for Conference of 6/29/2022.
2021-11-01
DISTRIBUTED for Conference of 11/5/2021.
2021-10-25
DISTRIBUTED for Conference of 10/29/2021.
2021-10-12
DISTRIBUTED for Conference of 10/15/2021.
2021-10-04
DISTRIBUTED for Conference of 10/8/2021.
2021-08-11
DISTRIBUTED for Conference of 9/27/2021.
2021-07-23
Brief of respondent United States in opposition filed.
2021-06-04
Motion to extend the time to file a response is granted and the time is further extended to and including July 23, 2021.
2021-06-03
Motion to extend the time to file a response from June 23, 2021 to July 23, 2021, submitted to The Clerk.
2021-05-18
Motion to extend the time to file a response is granted and the time is extended to and including June 23, 2021.
2021-05-17
Motion to extend the time to file a response from May 24, 2021 to June 23, 2021, submitted to The Clerk.
2021-04-20
Petition for a writ of certiorari filed. (Response due May 24, 2021)

Attorneys

George P. Naum, III
Ronald William Chapman IIChapman Law Group, Petitioner
Ronald William Chapman IIChapman Law Group, Petitioner
United States
Elizabeth B. PrelogarSolicitor General, Respondent
Elizabeth B. PrelogarSolicitor General, Respondent